| Beta-blockers - Summary of recommendations and evidence | ||
|---|---|---|
| Administer oral beta-blockers in the first 24 hours to patients without contraindications (signs of HF, low output symptoms, increased risk of cardiogenic shock, or other contraindications to beta-blockers). | IIa | B |
| Administer intravenous beta-blockers in intermediate- and high-risk patients with persistent ischemia, tachycardia, and hypertension provided that they do not show clinical/radiological signs of HF. | IIb | B |
| Administer intravenous beta-blockers to patients with risk factors for cardiogenic shock. | III | A |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.